全文获取类型
收费全文 | 95698篇 |
免费 | 8279篇 |
国内免费 | 5605篇 |
学科分类
医药卫生 | 109582篇 |
出版年
2024年 | 273篇 |
2023年 | 1337篇 |
2022年 | 3575篇 |
2021年 | 4626篇 |
2020年 | 3296篇 |
2019年 | 3263篇 |
2018年 | 3527篇 |
2017年 | 2927篇 |
2016年 | 3255篇 |
2015年 | 4644篇 |
2014年 | 5665篇 |
2013年 | 5183篇 |
2012年 | 7640篇 |
2011年 | 7862篇 |
2010年 | 4938篇 |
2009年 | 3745篇 |
2008年 | 5147篇 |
2007年 | 4898篇 |
2006年 | 4896篇 |
2005年 | 4673篇 |
2004年 | 3238篇 |
2003年 | 2881篇 |
2002年 | 2396篇 |
2001年 | 1923篇 |
2000年 | 1878篇 |
1999年 | 2123篇 |
1998年 | 1347篇 |
1997年 | 1310篇 |
1996年 | 986篇 |
1995年 | 926篇 |
1994年 | 794篇 |
1993年 | 504篇 |
1992年 | 624篇 |
1991年 | 523篇 |
1990年 | 484篇 |
1989年 | 431篇 |
1988年 | 387篇 |
1987年 | 313篇 |
1986年 | 263篇 |
1985年 | 228篇 |
1984年 | 136篇 |
1983年 | 97篇 |
1982年 | 46篇 |
1981年 | 57篇 |
1980年 | 33篇 |
1979年 | 70篇 |
1978年 | 25篇 |
1974年 | 28篇 |
1973年 | 23篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
《素问·调经论》曰:“络刺者,刺小络之脉也”。当今,络刺临床应用有所拓宽,已把各种浅刺放血法,如三棱针、皮肤针重刺出血法均归属于络刺范围。络刺具有活血化瘀、通络止痛、泻火解毒、启闭开窍之功。络刺是针灸临床常用方法之一,属九刺之一,具有操作简便、疗效显著的优点,若辨证准确,常可收到立竿见影的效果。现举数例如下。软组织挫伤王某,女,42岁。因肩周炎来我科治疗,每次治疗完毕后,嘱其每天多作肩部活动。由于本人治病心切,活动时用力过大,导致左肩胛部肌肉损伤,左侧肩部活动受限。以三棱针点刺患处3~5针,放血2~3ml,并拔罐治疗。取罐… 相似文献
993.
994.
本文就我国中药与植物药如何逐步实现现代化提出一些管见,如什么是中药现代化的过程,中药现代化要从国内、国外两个层面着手,不同地区和不同厂家要扬长避短,选择优势项目等方面进行了论述,以供讨论。 相似文献
995.
Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer. 总被引:3,自引:0,他引:3
Shaoliang Chen Like Yu Changying Jiang Yan Zhao Da Sun Shenyu Li Guoqing Liao Yangchun Chen Qing Fu Qun Tao Dan Ye Peisheng Hu Leslie A Khawli Clive R Taylor Alan L Epstein Dian Wen Ju 《Journal of clinical oncology》2005,23(7):1538-1547
PURPOSE: Tumor necrosis treatment (TNT) uses degenerating tumor cells and necrotic regions of tumors as targets for radioimmunotherapy. Previous studies in animal tumor models and clinical trials have demonstrated that when linked to the therapeutic radionuclide iodine-131, recombinant chimeric TNT antibody ((131)I-chTNT) can deliver therapeutic doses to tumors regardless of the location or type of malignancy. Therapeutic efficacy and toxicity of (131)I-chTNT in advanced lung cancer patients were studied in this pivotal registration trial. PATIENTS AND METHODS: Patients with advanced lung cancer were treated with systemic or intratumoral injection of (131)I-chTNT in eight oncology centers in China. The objective response rate (ORR) was assessed as the primary end point. RESULTS: All 107 patients who were entered onto the study and completed therapy had experienced treatment failure after prior radiotherapy or chemotherapy a mean of three times. The results showed an ORR of 34.6% (complete response, 3.7%; partial response, 30.8%; no change, 55.1%; and progressive disease, 10.3%) in all patients and 33% in 97 non-small-cell lung cancer patients. A biodistribution study demonstrated excellent localization of the radioactivity in tumors in both systemically and intratumorally injected patients. The most obvious adverse side effect was mild and reversible bone marrow suppression. CONCLUSION: Radioimmunotherapy with (131)I-chTNT was well tolerated and can be used systemically or locally to treat refractory tumors of the lung. 相似文献
996.
Enhancement of manumycin A-induced apoptosis by methoxyamine in myeloid leukemia cells. 总被引:1,自引:0,他引:1
Farnesyltransferase inhibitors (FTIs) are currently under investigation for leukemia treatment. We evaluated the FTI manumycin A (manumycin) in two myeloid leukemia cell lines (U937 and HL-60). Manumycin induced nitric oxide production and apoptosis of the leukemia cells. Nitric oxide or other reactive oxygen species may induce oxidative DNA damage, and the number of apurinic sites increased after manumycin treatment, which was reversed by concurrent treatment with N-acetyl-L-cysteine. Since repair of DNA damage is important to cell survival, we hypothesized that methoxyamine, an inhibitor of base-excision repair, would enhance the antineoplastic effect of manumycin. The combination of manumycin and methoxyamine resulted in enhanced apoptosis by six criteria increased annexin V binding, release of mitochondrial cytochrome c into the cytosol, activation of caspase-9, activation of caspase-3, specific cleavage of poly-adenosyl ribose polymerase, and increase in the sub-G1 cell cycle fraction. The drug combination enhanced inhibition on the soft agar clonogenic assay and on the formazan dye cell viability assay. The effects of manumycin or manumycin plus methoxyamine on apoptosis were blocked by N-acetyl-L-cysteine, and partially by nitric oxide synthase inhibitors or scavenger of peroxide. We conclude that methoxyamine enhances manumycin-induced apoptosis in myeloid leukemia cells. 相似文献
997.
Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. 总被引:17,自引:0,他引:17
Su Jeong Lee Sin Yeob Lee Hyo-Sung Jeon Sun Ha Park Jin Sung Jang Ga Young Lee Ji Woong Son Chang Ho Kim Won Kee Lee Sin Kam Rang Woon Park Tae-In Park Young Mo Kang In-San Kim Tae Hoon Jung Jae Yong Park 《Cancer epidemiology, biomarkers & prevention》2005,14(3):571-575
Angiogenesis is an essential process in the development, growth, and metastasis of malignant tumors including lung cancer. DNA sequence variations in the vascular endothelial growth factor (VEGF) gene may lead to altered VEGF production and/or activity, thereby causing interindividual differences in the susceptibility to lung cancer via their actions on the pathways of tumor angiogenesis. To test this hypothesis, we investigated the potential association between three VEGF polymorphisms (-460T > C, +405C > G, and 936C > T)/haplotypes and the risk of lung cancer in a Korean population. VEGF genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency matched for age and sex. VEGF haplotypes were predicted using Bayesian algorithm in the phase program. Compared with the combined +405 CC and CG genotype, the +405 GG genotype found associated with a significantly decreased risk of small cell carcinoma [SCC; adjusted odds ratio (OR), 0.36; 95% confidence interval (95% CI), 0.17-0.78]. The 936 CT genotype and the combined 936 CT and TT genotype were also associated with a significantly decreased risk of SCC compared with the 936 CC genotype (adjusted OR, 0.47; 95% CI, 0.26-0.85 and adjusted OR, 0.44; 95% CI, 0.24-0.80, respectively). Haplotype CGT was associated with a significantly decreased risk of SCC (adjusted OR, 0.39; 95% CI, 0.18-0.87), whereas haplotype TCC conferred a significantly increased risk of SCC (adjusted OR, 1.63; 95% CI, 1.14-2.33). None of the VEGF polymorphisms studied significantly influenced the susceptibility to lung cancer except SCC. However, haplotypes TCT and TGT were significantly associated with the risk of overall lung cancer, respectively (adjusted OR, 0.38; 95% CI, 0.25-0.60 and adjusted OR, 3.94; 95% CI, 2.00-7.76, respectively). These effects of haplotypes TCT and TGT on lung cancer risk were observed in three major histologic types of lung cancer. These results suggest that the VEGF gene may be contribute to an inherited predisposition to lung cancer. 相似文献
998.
Raghavendra Vasudeva Murthy Gunnar Arbman Jingfang Gao G David Roodman Xiao-Feng Sun 《Clinical cancer research》2005,11(6):2293-2299
PURPOSE: Legumain, a novel asparaginyl endopeptidase, has been observed to be highly expressed in several types of tumors including colorectal cancer. However, there is no study examining the relationship of legumain expression to clinocopathologic and biological variables in colorectal cancers. EXPERIMENTAL DESIGN: We investigated legumain expression in 164 primary colorectal cancers, 34 corresponding distant normal mucosa samples, 89 adjacent normal mucosa samples, and 33 lymph node metastases using immunohistochemistry. We also did Western blotting analysis on three additional colorectal cancers and three colonic cell lines. RESULTS: Legumain expression was increased in primary tumors compared with distant or adjacent normal mucosa (P < 0.05), but there was no significant change between primary tumors and metastases (P > 0.05). Legumain expression was positively related to poorer differentiation/mucinous carcinoma (P = 0.04), higher degree of necrosis (P = 0.03) and apoptosis (P < 0.0001), positive proliferating cell nuclear antigen (P < 0.0001) and p53 expression (P = 0.049), and had a positive tendency towards stromelysin 3 (P = 0.058) and PINCH positivity (P = 0.05). The patients with tumors that showed both weak and lower percentage of the legumain expression, either in tumor (P = 0.01) or in stroma (P = 0.04), had a better prognosis. CONCLUSIONS: The legumain expression may be involved in colorectal cancer development and have a prognostic value in the patients. 相似文献
999.
1000.
目的研究细胞因子诱导杀伤细胞(cytokine induced killer,CIK)对慢性粒细胞白血病(chronic myeloid leukemia,CML)中G0期原始干细胞(CD34+)的杀伤作用。方法5例CML慢性期患者外周血标本在体外诱导培养CIK细胞,流式细胞仪(FCM)检测其表型。G带法检测CIK细胞核型。应用免疫磁珠技术分选CD34+CML白血病细胞,AO染色后利用FCM检测CIK细胞对G0期CD34+CML白血病细胞的杀伤作用。半固体培养法检测CIK细胞对正常骨髓CFU-GM、BFU-E集落的影响。结果CIK细胞在培养第3周时,CD3+细胞数量达(97.29±3.55)%,CD3+CD56+细胞绝对数量增加了356倍,染色体分析证实,CIK细胞为正常核型,流式细胞仪检测CIK细胞对G0期CD34+CML白血病细胞平均杀伤率为66.73%。对照组与加入CIK细胞组的CFU-GM集落数分别为150±16和145±20,差异无统计学意义,P=0.38;两组的BFU-E集落数分别为68±5和65±8,差异无统计学意义,P=0.23。集落类型、大小两组相似,差异无统计学意义,P=0.46。结论CIK细胞可从CML患者外周血中大量扩增,来源于正常淋巴细胞,对G0期CD34+CML白血病细胞有明显抑制作用,对正常造血前体细胞无抑制作用,可作为过继细胞免疫治疗的效应细胞治疗CML。 相似文献